Autres langues Terumo Corporation

Actions

4543

JP3546800008

Equipement, fournitures et distribution médicale

Marché Fermé - Japan Exchange Autres places de cotation 08:23:37 18/05/2026			Varia. 5j.	Varia. 1 janv.
2 275,00 ^JPY	+18,37%		+15,34%	+0,22%

04:36	Le Nikkei recule pour la troisième séance consécutive, plombé par la déroute obligataire mondiale et le conflit au Moyen-Orient	RE
15/05	Terumo : le bénéfice progresse de 16% au titre de l'exercice 2025	MT

Autres langues

11:41	Terumo : Q&A Session at the Financial Results for the Fiscal Year Ended March 31, 2026
10:33	Terumo : Financial Results for the Fiscal Year Ended March 31, 2026 (FY2025)(with note)
04:36	Japan's Nikkei slips for third day as global bond selloff, Mideast war weigh
15/05	Terumo's Profit Rises 16% Fiscal Year 2025
15/05	Terumo : GS26 Final Year and Beyond & Terumo Neuro Growth Roadmap
15/05	Terumo : Financial Results for the Fiscal Year Ended March 31, 2026 (FY2025)
15/05	Terumo : IFRS Financial Results for the Fiscal Year Ended March 31, 2026
15/05	Terumo Corporation Reports Earnings Results for the Full Year Ended March 31, 2026
15/05	Terumo : Announces Candidates for Directors
14/05	OrganOx Announces Appointment of Naoya Iwata as CEO & President
30/04	Terumo : Issued its First U.S. Dollar-Denominated Senior Unsecured Notes
22/04	Humacyte, Inc. Announces the Appointment of Jim Mercadante as Chief Commercial Officer
15/04	Terumo Corporation Joins the Healthcare Plastics Recycling Council
09/04	Terumo Deepens Costa Rica Investment Amid Medtech Growth
19/03	Tata Elxsi and Terumo Corporation Launch Global Offshore Development Center
19/03	Tata Elxsi launches global offshore development center for Terumo Corporation
02/03	Shoulder Innovations, Inc. Announces Board and Committee Changes, Effective February 26, 2026
25/02	Galderma Announces Triple Approval of New Restylane Syringe in the EU, the U.S., and Canada
19/02	Q-Sera announces the first launch of blood collection tubes using its patented Rapclot technology in Japan, opening opportunities for additional global partnerships
16/02	Terumo : Q&A Session at the Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2026
16/02	Terumo : Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2026 (FY2025)(with note)
13/02	Terumo : Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2026 (FY2025)
13/02	Terumo : IFRS Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2026
13/02	Terumo Corporation Reports Earnings Results for the Nine Months Ended December 31, 2025
10/02	Cartera Asiática: Últimas compras